Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark

Showing results (201-210 of 2,048) with videos related to

Pageof 205
Sort By:
The American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark Fendrick
Urology Practice|October 25, 2024
Eliminating Consumer Cost-Sharing for the Entire Prostate Cancer Screening PathwayArnav Srivastava, A Mark Fendrick
Health Services Research|February 17, 2026
Use of High- and Low-Value Care Among Traditional Medicare Beneficiaries With and Without MedigapSungchul Park, A Mark Fendrick
Plasmid|December 4, 2002
When phage, plasmids, and transposons collide: genomic islands, and conjugative- and mobilizable-transposons as a mosaic continuumA Mark Osborn, Dietmar Böltner
Respiratory Physiology & Neurobiology|July 20, 2002
Hypoxic pulmonary vasoconstriction: cyclic adenosine diphosphate-ribose, smooth muscle Ca(2+) stores and the endotheliumA Mark Evans, Michelle Dipp
Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark Fendrick
Journal of Pediatric Hematology/Oncology|October 26, 2021
Pediatric Mycosis Fungoides: Retrospective Analysis of a Series With CD8 + Profile and Female PredominanceSeda Purnak, Lawrence A Mark
BMJ (Clinical Research Ed.)|February 16, 2022
Tigray: the challenges of providing care in unimaginable conditionsOra Paltiel, A Mark Clarfield
Plasmid|January 9, 2004
Structural comparison of the integrative and conjugative elements R391, pMERPH, R997, and SXTDietmar Böltner, A Mark Osborn
The American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark Fendrick
Pageof 205

Showing results (201-210 of 2,048) with videos related to

Sort By:
Pageof 205
The American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark Fendrick
Urology Practice|October 25, 2024
Eliminating Consumer Cost-Sharing for the Entire Prostate Cancer Screening PathwayArnav Srivastava, A Mark Fendrick
Health Services Research|February 17, 2026
Use of High- and Low-Value Care Among Traditional Medicare Beneficiaries With and Without MedigapSungchul Park, A Mark Fendrick
Plasmid|December 4, 2002
When phage, plasmids, and transposons collide: genomic islands, and conjugative- and mobilizable-transposons as a mosaic continuumA Mark Osborn, Dietmar Böltner
Respiratory Physiology & Neurobiology|July 20, 2002
Hypoxic pulmonary vasoconstriction: cyclic adenosine diphosphate-ribose, smooth muscle Ca(2+) stores and the endotheliumA Mark Evans, Michelle Dipp
Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark Fendrick
Journal of Pediatric Hematology/Oncology|October 26, 2021
Pediatric Mycosis Fungoides: Retrospective Analysis of a Series With CD8 + Profile and Female PredominanceSeda Purnak, Lawrence A Mark
BMJ (Clinical Research Ed.)|February 16, 2022
Tigray: the challenges of providing care in unimaginable conditionsOra Paltiel, A Mark Clarfield
Plasmid|January 9, 2004
Structural comparison of the integrative and conjugative elements R391, pMERPH, R997, and SXTDietmar Böltner, A Mark Osborn
The American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark Fendrick
Pageof 205